Securities Purchased in Underwritings Involving Transactions
with Sanford C. Bernstein and Co.


Subject to Rule 10f-3 Under the Investment Company Act of
1940





  10f-3 Transactions - January 1, 2015 - March 31,
2015





AB Funds


Portfolio
Security
Date
Purchased
*
Shares
Purchased
Price per
Share
Underwriting
Commission**
Shares
Purchased
by AB
including
the Funds
Total
Shares
Offered~
% of
Offering
Purchased
by AB
including
the Funds
***
Purchased
From
Shares
Held
3/31/15











AB Small Cap
Growth
Portfolio
Spark
Theraputics,
Inc.
1/30/2015

14,272
 $
23.00
 $
1.6100

200,000

7,000,000
2.86%
Credit
Suisse ^
0
AVPS Small
Cap Growth
Portfolio
Spark
Theraputics,
Inc.
1/30/2015

844
 $
23.00
 $
1.6100

200,000

7,000,000
2.86%
Credit
Suisse ^
0
AB Global
Thematic
Growth Fund
Spark
Theraputics,
Inc.
1/30/2015
6,979
 $
23.00
 $
1.6100

200,000

7,000,000
2.86%
Credit
Suisse ^
0
AVPS Global
Thematic
Growth
Portfolio
Spark
Theraputics,
Inc.
1/30/2015
1,294
 $
23.00
 $
1.6100

200,000

7,000,000
2.86%
Credit
Suisse ^
0
AB Select US
Equity
Portfolio
Spark
Theraputics,
Inc.
1/30/2015
3,402
 $
23.00
 $
1.6100

200,000

7,000,000
2.86%
Credit
Suisse ^
0
AB Select US
Long/Short
Portfolio
Spark
Theraputics,
Inc.
1/30/2015

18,711
 $
23.00
 $
1.6100

200,000

7,000,000
2.86%
Credit
Suisse ^
0
* With respect to the transactions, the issuer
was incorporated in March 2013 less than three
years, but the predecessor
research efforts were established in 2004 at the
Childrens Hospital of Philadelpihias Center for
Cellular and Molecular
Therapeutics.  The securities purchased were 1 part
of an issue registered under the Securities Act of
1933 and offered to the
public, 2 purchased prior to the end of the first day
on which any sales were made, at a price not more than
the price paid by
each other purchaser of securities in the offering or
in any concurrent offering of the securities if not
offered for subscription
upon exercise of rights or, if so offered, purchased
on or before the fourth day preceding the day on which
the rights offering
terminated, and 3 offered pursuant to an underwriting or
similar agreement under which the underwriters were
committed to
purchase all of the securities offered, except those
purchased by others pursuant to a rights offering, if the
underwriters
purchased any of the securities.













** The commission, spread or profit received or to be
received by the principal underwriters was determined
by the
appropriate officers of the Adviser to be reasonable
and fair compared to the commission, spread or profit
received by other
such persons in connection with the underwriting of
similar securities sold during a comparable period of time.













~ Not inclusive of 15% over-allotment of shares greenshoe
option from the full exercise of the underwriters in the
offering.













*** Aggregate purchases by all AB buy-side clients, including
the Fund, did not exceed 25% of the pricipal amount of the
Offering.













^ Sanford C. Bernstein  Co., LLC SCBCo., an affiliated
broker-dealer of the Fund, was a member of the underwriting
syndicate for
this transaction and was allocated 10% of the Offering.
Other members of the underwriting syndicate for the Offering
were as
follows: J.P. Morgan Securities LLC, Credit Suisse Securities
USA LLC,  and Cowen and Company LLC.







ablegal -  2968760 v1